ArticleScientific reports2025
Stereology with OPEN-Stereo: low-cost, accessible, and accurate cellular quantification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Critical to rigor in neurodegeneration research is the accurate and unbiased assessment of degenerative phenotypes, where stereology remains the gold standard, yet its widespread adoption is hindered by the high cost of proprietary systems. We developed OPEN-Stereo, an open-source stereology platform that integrates standard microscopy hardware with intelligent, software-based calibration and positional control. Innovative use of computer vision methods, multi-scale image-based calibration and navigation, are combined with open-loop stage data to establish a global positioning system without costly hardware, while remaining within the accuracy tolerances inherent to stereological sampling. OPEN-Stereo implements the stereological random sampling method for unbiased cell counting. Validation using samples previously analyzed on commercial systems demonstrated up to 95% agreement in cell counts across multiple brain regions, with statistical equivalence confirmed by two-way repeated measures ANOVA (p = 0.8962). Beyond enabling accessibility, OPEN-Stereo's image-analytic architecture enables stereology to evolve beyond manual practice, toward AI-driven cell identification and counting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.